These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29145956)

  • 1. Myofilament Calcium-Buffering Dependent Action Potential Triangulation in Human-Induced Pluripotent Stem Cell Model of Hypertrophic Cardiomyopathy.
    Wang L; Kryshtal DO; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Knollmann BC
    J Am Coll Cardiol; 2017 Nov; 70(20):2600-2602. PubMed ID: 29145956
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
    Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
    J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.
    Zile MA; Trayanova NA
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):418-428. PubMed ID: 28648627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of the excitation-contraction coupling machinery and its relation to myofibrillogenesis in human iPSC-derived skeletal myocytes.
    Lainé J; Skoglund G; Fournier E; Tabti N
    Skelet Muscle; 2018 Jan; 8(1):1. PubMed ID: 29304851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy. An electrophysiological study.
    Coltart DJ; Meldrum SJ
    Br Med J; 1970 Oct; 4(5729):217-8. PubMed ID: 5528752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
    Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
    J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
    Prajapati C; Ojala M; Aalto-Setälä K
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient with a pathogenic myosin binding protein C (MYBPC3) p.Arg502Trp mutation.
    Holliday M; Ross SB; Lim S; Semsarian C
    Stem Cell Res; 2018 Dec; 33():56-59. PubMed ID: 30316040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy.
    Davis J; Davis LC; Correll RN; Makarewich CA; Schwanekamp JA; Moussavi-Harami F; Wang D; York AJ; Wu H; Houser SR; Seidman CE; Seidman JG; Regnier M; Metzger JM; Wu JC; Molkentin JD
    Cell; 2016 May; 165(5):1147-1159. PubMed ID: 27114035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.
    Hallas T; Eisen B; Shemer Y; Ben Jehuda R; Mekies LN; Naor S; Schick R; Eliyahu S; Reiter I; Vlodavsky E; Katz YS; Õunap K; Lorber A; Rodenburg R; Mandel H; Gherghiceanu M; Binah O
    J Cell Mol Med; 2018 Feb; 22(2):913-925. PubMed ID: 29193756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function.
    Herron TJ; Rocha AM; Campbell KF; Ponce-Balbuena D; Willis BC; Guerrero-Serna G; Liu Q; Klos M; Musa H; Zarzoso M; Bizy A; Furness J; Anumonwo J; Mironov S; Jalife J
    Circ Arrhythm Electrophysiol; 2016 Apr; 9(4):e003638. PubMed ID: 27069088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy.
    Dementyeva EV; Medvedev SP; Kovalenko VR; Vyatkin YV; Kretov EI; Slotvitsky MM; Shtokalo DN; Pokushalov EA; Zakian SM
    Biochemistry (Mosc); 2019 Mar; 84(3):291-298. PubMed ID: 31221067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the Development of Novel Therapy for Hypertrophic Cardiomyopathy.
    Matsuura K
    Int Heart J; 2018; 59(5):914-916. PubMed ID: 30259904
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of optical action potentials in human induced pluripotent stem cells-derived cardiomyocytes to predict drug-induced cardiac arrhythmias.
    Lu HR; Hortigon-Vinagre MP; Zamora V; Kopljar I; De Bondt A; Gallacher DJ; Smith G
    J Pharmacol Toxicol Methods; 2017 Sep; 87():53-67. PubMed ID: 28501647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rigorous Phenotyping of Cardiac iPSC Preparations Requires Knowledge of Their Resting Potential(s).
    Giles WR; Noble D
    Biophys J; 2016 Jan; 110(1):278-80. PubMed ID: 26745430
    [No Abstract]   [Full Text] [Related]  

  • 17. The Genetic and Molecular Bases for Hypertrophic Cardiomyopathy: The Role for Calcium Sensitization.
    Ren X; Hensley N; Brady MB; Gao WD
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):478-487. PubMed ID: 29203298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular action potential in hypertrophic obstructive cardiomyopathy.
    Coltart DJ; Meldrum SJ
    Br Heart J; 1972 Feb; 34(2):204. PubMed ID: 4257455
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac α1-Adrenoceptors and Inotropy: Myofilament Ca2+ Sensitivity, Intracellular Ca2+ Mobilization, Signaling Pathway, and Pathophysiological Relevance.
    Endoh M
    Circ Res; 2016 Aug; 119(5):587-90. PubMed ID: 27539971
    [No Abstract]   [Full Text] [Related]  

  • 20. Estradiol protection against toxic effects of catecholamine on electrical properties in human-induced pluripotent stem cell derived cardiomyocytes.
    El-Battrawy I; Zhao Z; Lan H; Schünemann JD; Sattler K; Buljubasic F; Patocskai B; Li X; Yücel G; Lang S; Nowak D; Cyganek L; Bieback K; Utikal J; Zimmermann WH; Ravens U; Wieland T; Borggrefe M; Zhou XB; Akin I
    Int J Cardiol; 2018 Mar; 254():195-202. PubMed ID: 29407091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.